Tristan Balcer

MOBILE: 704-***-****

EMAIL: acrkys@r.postjobfree.com

ADDRESS: *** ******* **, *********, ** 21212

SUMMARY OF SKILLS

Performing financial, risk, economic, and industry analysis and convey the data in a user-friendly approach

Formulating, analyzing, and applying various financial models including DCF, CAPM, and WACC

Utilizing Excel, Word, and PowerPoint to properly convey and present analysis

Experience in portfolio, industry, and company specific risk analysis

Client focus approach to matching portfolio credit risk commensurate to return expectations, and overall risk appetite

EDUCATION

Bachelors, Business Administration - Finance, Honors Sept. 2005 - April 2010

University of Windsor, Windsor, Ontario, Canada

CERTIFICATIONS

2015 Level II CFA Candidate Present

Successfully passed Level I CFA exam

Certified Business Appraiser - CBA, Institute of Business Appraisers – In Progress Present

Successfully passed the comprehensive six hour examination and received the highest score among the self-study test results.

EMPLOYMENT

Related Experience:

Sr Risk Underwriter, Euler Hermes, Baltimore, MD, United States October 2014 - Present

Responsible for making credit/risk decisions based on financial statements, risk profile, financial flexibility, and overall credit worthiness. Provide effective communication to the client and sales team explaining decisions, whether favorable or unfavorable, while continuing to demonstrate excellent customer service. Frequently travel to meet clients to discuss their objectives, service their risk portfolio, and work with the client to execute an achievable plan. Focus on underwriting credit risk in the manufacturing industry and manage a portfolio of 50+ companies.

Credit Analyst, Euler Hermes, Baltimore, MD, United States April 2013 - October 2014

Daily activities include monitoring the risk exposure of buyers in the manufacturing portfolio, grading the buyer, and recommending an exposure limit. Responsible for the majority of high risk/exposure buyer portfolio (including buyers with $1B+ in financial exposure), performing in depth financial/credit/risk analysis and presenting to a credit committee on a weekly basis. Responsible for a semi-annual automotive industry report, made available internally to other analysts, and externally to clients and general public.

Credit Analyst, Aerotek, Baltimore, MD, United States April 2012 – April 2013

Responsible for analyzing and interpreting a firm’s ability to meet its upcoming or existing obligations. Daily activities include but not limited to reviewing credit applications from new and existing clients, determining the aggregate financial exposure, and setting both a credit limit and risk rating based on the clients’ Duns & Bradstreet report, financial flexibility, and payment history. Review, analyze, and make comprehensive recommendation reports for new high-risk clients. Created and implemented a new template for the credit department for reviewing publicly traded companies rated by Egan-Jones Rating Company.

Business Valuation Project Manager, The Efird Corporation, Charlotte, NC, United States July 2010- April 2012

In charge of the creation and development of a new business unit –Business Valuation, with emphasis on product diversification and risk mitigation. Developed financial models and quantitative analysis templates utilizing both Excel and Word. Created sample valuation reports for marketing to existing clientele. Assist the president with specific business decisions as well as day-to-day operations.

Partner Specialist, Van Der Moolen Specialists LLC, New York, NY, United States June - Sept. 2006

A market-making specialist firm for stock transactions operating on the New York Stock Exchange. Responsible for completing gaps between buyer/seller imbalances. Ensured that the specialist was matching the best bid with the best offer. Analyzed both fundamental and technical analysis during intraday and after-hours trading. Performed opening, closing, and processed limit orders for 8 – 10 stocks daily with the use of OARS. Conveyed information back and forth from specialist to brokers. Autonomously performed research on pharmaceutical companies showing which firm had what drugs in what stages in the pipeline and the significance to the shareholder.